Abstract:Stroke is the leading cause of death and disability in ageing individuals. Previous epidemiological investigations and basic studies have demonstrated that estrogen replacement therapy exerted neuroprotective effects against stroke in menopausal women and ovariectomised (OVX) animals. The underlying mechanism remains unclear. ndrg2 is a new gene cloned in 2001 related to cell proliferation and differentiation, and stress responses. Our previous studies found that ndrg2 is specifically expressed in astrocytes in the brain and played an important role in cerebral ischaemic injury. However, the role of ndrg2 in estrogen neuroprotection against cerebral ischaemia has not been reported. In in vivo experiments, adult female C57 mice and ndrg2 gene knockout (ndrg2–/–) female mice were OVX and 7 days later treated with 50 μg kg–1 17β-estradiol (E2), 100 μg kg–1 E2, 2 mg kg–1 ERα agonist (PPT), or 8 mg kg–1 ERβ agonist (DPN) for 14 days. We detected the expression of ndrg2 mRNA and protein in brain tissue using real-time polymerase chain reaction (PCR), western blot, and immunofluorescence double labelling. We constructed a middle cerebral artery occlusion (MCAO) ischaemia model, and we also measured the expression of ndrg2 mRNA and protein at different times after reperfusion in the ischaemic penumbra. Triphenyltetrazolium chloride (TTC) staining was used to determine the ischaemic injury. In in vitro experiments, primary cultured astrocytes received E2, DPN, and PPT treatment. Real-time PCR and western blot were used to detect the expression of astrocyte ndrg2 mRNA and protein. We constructed an oxygen and glucose deprivation (OGD) model, and detected the expression of astrocyte ndrg2 mRNA and protein at different times after OGD. E2 or DPN treatment significantly up-regulated the expression of ndrg2 mRNA and protein in primary astrocytes and in the brain of OVX female. Expression of ndrg2 mRNA and protein in the ischaemic penumbra region after cerebral ischaemia was significantly increased 6 h after reperfusion and peaked at 24 h with nuclear translocation. Expression of ndrg2 mRNA and protein in primary astrocytes after OGD injury was significantly increased at 2 h after reoxygenation and peaked at 6 h also with nuclear translocation. ndrg2–/– female mice exhibited significantly larger infarct volume than ndrg2+/+ female mice. E2 or DPN replacement therapy significantly reduced infarct volume in ndrg2+/+-OVX female mice, but 50 μg kg–1 E2 or 8 mg kg– DPN replacement therapy did not significantly reduce infarct volume in ndrg2–/–-OVX female mice. Our study found that astrocyte ndrg2 is a target gene for estrogen and ERβ, and that estrogen or DPN replacement treatment significantly reduced cerebral ischaemia injury in OVX mice. Astrocyte ndrg2 is the key molecule mediating the neuroprotective effects of estrogen and ERβ against cerebral ischaemia and provides a potential new molecular target for estrogen neuroprotection.

Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice

Abstract WP346: A Cost-effective and Reproducible Mouse Model of Intracranial Aneurysm: Renal Hypertension and Local Hemodynamic Change Combined with Elastase Infusion

Generation of Astrocyte-Specific MAOB Conditional Knockout Mouse with Minimal Tonic GABA Inhibition

Transgenic mice for conditional gene manipulation in astroglial cells

Generation of Astrocyte-specific BEST1 Conditional Knockout Mouse with Reduced Tonic GABA Inhibition in the Brain

Sex‐specific impact of brain estrogen deficiency on astrocyte reactivity, neurodegeneration, and memory loss in aromatase knockout mouse models

Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters

OR09-03 Brain Aromatase Is Essential for Regulation of Sexual Activity in Male Mice

Local and CNS-Wide Astrocyte Intracellular Calcium Signaling Attenuation In Vivo with CalExflox Mice

Generation And Characterization Of Androgen Receptor Knockout (Arko) Mice: An In Vivo Model For The Study Of Androgen Functions In Selective Tissues

Ndrg2: a Novel Target for Estrogen Neuroprotection Against Cerebral Ischaemia

Rapid and local neuroestrogen synthesis supports long‐term potentiation of hippocampal Schaffer collaterals‐cornu ammonis 1 synapse in ovariectomized mice

Dicer Deletion in Astrocytes Inhibits Oligodendroglial Differentiation and Myelination

Aromatase-null mice expressing enhanced green fluorescent protein in germ cells provide a model system to assess estrogen-dependent ovulatory responses

Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke

Astrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusion

Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice

Abstract 16: Inhibiting Ezh2 Is Neuroprotective After Stroke In Aged Mice

Inhibition of miR-181a protects female mice from transient focal cerebral ischemia by targeting astrocyte estrogen receptor-α.

Characterizing the Neuroendocrine and Ovarian Defects of Androgen Receptor-Knockout Female Mice.

Estrogen Regulates the Expression of Ndrg2 in Astrocytes